LEP and metabolic syndrome: Nfe2l2 deficiency in Lep(ob/ob) mice has been reported to reduce insulin-stimulated AKT1 phosphorylation along with a slight decrease in glucose transporter type 4 (GLUT4) expression, which reduced WAT mass and prevented hepatic lipid accumulation but induced insulin resistance and dyslipidemia [84].